P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

November 2002

Features

Highlights of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy

Lawrence M. Prescott, PhD

Pharmaceutical-Approval Update

Pharmaceutical-Approval Update: Oncology

Marvin M. Goldenberg, PhD, describes new treatments for colorectal, breast, and advanced prostate cancer.
Marvin M. Goldenberg, PhD

Step-Down Treatment of Uncomplicated Gastroesophageal Reflux Disease in Patients Taking Twice-Daily Lansoprazole

It is possible to safely reduce the dose of medication for patients with GERD.
Cameron C. Lindsey, PharmD, Maqual R. Graham, PharmD, and Lauri A. Witt, PharmD

A Prospective Study of Antibiotic Cost Containment in a University Teaching Hospital over a 13-Year Period

A unique antibiotic monitoring program has succeeded in reducing costs.
Arpi G. Kuyumjian, PharmD, Jerome F. Levine, MD, Peter A. Gross, MD, and Antonia Lo Presti, MD

CE

The Impact of NSAID Selection on Gastrointestinal Injury and Risk for Cardiovascular Events: Identifying and Treating Patients at Risk

New COX-1/COX-2 NSAIDs relieve pain with less gastrointestinal damage than past pain relievers but may increase the risk of cardiovascular injury.
Richard L. Ruffalo, MD, PharmD, Robert L. Jackson, MD, and Joshua J. Ofman, MD, MSHS

A Clinician’s Guide to the Selection of NSAID Therapy

The authors review the potential gastrointestinal and cardiovascular risks posed by COX-1/COX-2 NSAIDs.
A. Mark Fendrick, MD, and Susan M. Garabedian-Ruffalo, PharmD

Guest Commentary

The Road Not Taken: Changing Physician-Prescribing Behaviors

The difficulty in educating professionals who prescribe medications is not unlike the challenge of fixing a dangerous road.
Peter Teichman, MD, MPA

Departments

Editorial

National Drug and Therapeutic Index

Editor-in-Chief David Nash discusses the National Drug and Therapeutic Index.
David B. Nash, MD, MBA

Medication Errors

Sample Medications: Safe Management Is a Difficult but Necessary Process

Precautions must be taken when sample medications are dispensed.
Matthew Grissinger

Drug News

New Drugs/Drug News

The latest information about approvals, indication changes, industry updates, and news from the FDA.

Prescription Washington

Government’s Draft Guidelines on Drugs Are Murky At Best

Mr. Barlas discusses the ambiguity of the new federal guidelines for PBMs.
Stephen Barlas

Drug Forecast

Novel Treatment of Allergic Asthma and Seasonal Allergic Rhinitis: Focus on Omalizumab (Xolair®)

Omalizumab is being touted as a new treatment for patients with allergic disorders.
Boris Nogid, PharmD, and Timothy S. McCall, RPh

P&T Snapshot

NSAID Usage in U.S. Hospitals